BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Inaugural Lectures | Camille Goemans and Sebastian Waszak
DTSTART:20240527T171500
DTEND:20240527T190000
DTSTAMP:20260427T224657Z
UID:856768fea165b976e913c97405e607b222d0c5a847c628afdad0fb5d
CATEGORIES:Inaugural lectures - Honorary Lecture
DESCRIPTION:Prof Camille Goemans Prof Sebastian Waszak\nProgram:\n\n	17:15
  - 17:25 Welcome by Andy Oates\, Dean SV and introduction by Melanie Bloke
 sch\, Institute Director GHI\n	17:25 - 17:55 Lecture by Camille Goemans: T
 he impact of antibiotics on human gut microbes\n	18:00 - 18:10 Introductio
 n by Elisa Oricchio\, Institute Director ISREC\n	18:10 - 18:40 Lecture by 
 Sebastian Waszak: Code Against Cancer: Empowering Neuro-Oncology with Comp
 utational Science\n	18:40 - 18:45 Closure by Andy Oates\n	18:45 Apéritif\
 n\nLocation: SV 1717\nRegistration by May 21\, 2024\n\nCamille Goemans | T
 he impact of antibiotics on human gut microbes\nAbstract: Over the last ce
 ntury\, antibiotics have been one of the main pillars of modern medicine a
 nd have considerably contributed to the increase of our life expectancy. H
 owever\, their overuse combined to the rapid adaptation power of bacteria 
 has led to the emergence of antibiotic resistance and to health issues ass
 ociated with their impact on the human gut microbiota. In this lecture\, I
  will discuss how antibiotics impact human gut microbes and touch on the c
 oncepts of cross-resistance and collateral sensitivity. In addition\, I wi
 ll introduce our current work on how antibiotics affect diverse bacterial 
 species\, how antibiotic resistance emerges and spreads in the gut and str
 ategies to design better treatment.\nBio: Camille joined EPFL as an Assist
 ant Professor in September 2023. Her lab focuses on understanding how anti
 biotics affect the diverse bacteria from the human gut microbiota and how 
 they contribute to the development of antibiotic resistance. Camille obtai
 ned her Master’s degrees in Biomedical Sciences from the UCLouvain after
  which she completed her PhD at the de Duve Institute in the laboratory of
  Prof. Jean-François Collet\, studying bacterial responses to stress. She
  then pursued post-doctoral studies at the EMBL in the laboratory of Dr. N
 assos Typas\, where she gained expertise into systems biology focusing on 
 the impact of antibiotics on the human gut microbiota.\n\nSebastian Waszak
  | Code Against Cancer: Empowering Neuro-Oncology with Computational Scien
 ce\nAbstract: The lecture will present the role of computational science &
  engineering in neuro-oncology\, emphasising advancements in diagnostics a
 nd genome-driven therapeutic strategies. It will address the contribution 
 of biomedical data science to precision medicine\, particularly for childr
 en and young adults with glioma\, and discuss the application of statistic
 al methods and artificial intelligence in analysing and integrating real-w
 orld clinical datasets. The presentation will present examples where compu
 tational studies have led to the discovery of novel brain tumour entities 
 and biomarkers of therapy response. Finally\, it will introduce new resear
 ch directions for rapid and longitudinal brain tumour surveillance to opt
 imise therapeutic decision-making with real-time information about molecu
 lar tumour states.\nBio: Sebastian Waszak is an Assistant Professor at the
  School of Life Sciences and leads the Laboratory of Computational Neuro-O
 ncology. His research focuses on brain tumours and the development of comp
 utational methods for rapid diagnostics\, minimally invasive brain tumour 
 surveillance\, and genome-driven precision medicine. He obtained his PhD i
 n bioengineering & biotechnology and completed his postdoctoral training i
 n cancer genomics. He has published 80 papers in basic science and medica
 l journals\, received national and international awards\, and delivered in
 vited lectures at international conferences. His research findings have le
 d to novel entities in the latest edition of the WHO Classification of Tum
 ours series and have contributed to the revision of clinical practice guid
 elines in neuro-oncology.\n\n\n 
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR
